Pacira BioSciences, Inc. (PCRX)
Receivables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 700,966 | 674,978 | 666,823 | 541,533 | 420,830 |
| Receivables | US$ in thousands | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue ÷ Receivables
= $700,966K ÷ $—K
= —
Based on the provided data, it appears that Pacira BioSciences, Inc. has not disclosed any specific figures for its Receivables Turnover ratio for the years 2020 to 2024.
The Receivables Turnover ratio is a measure of how efficiently a company is collecting its accounts receivables during a specific period. It is calculated by dividing the net credit sales by the average accounts receivable during the period. A higher turnover ratio indicates that the company is collecting its receivables more quickly.
In the absence of specific data points, it is challenging to assess Pacira BioSciences, Inc.'s performance in managing its receivables turnover over the specified years. Detailed financial data would be required to evaluate the effectiveness of the company in efficiently collecting its accounts receivables.
Peer comparison
Dec 31, 2024